​

United Therapeutics Ownership | Who Owns United Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

United Therapeutics Ownership Summary

United Therapeutics is owned by 96.30% institutional investors, 2.03% insiders, and 1.67% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 12.17% of UTHR shares. iShares Core S&P Mid-Cap ETF is the top mutual fund, with 3.56% of its assets in United Therapeutics shares.

UTHR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockUnited Therapeutics96.30%2.03%1.67%
SectorHealthcare Stocks 246.48%12.12%-158.60%
IndustryBiotech Stocks 384.82%11.76%-296.58%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de5.29M12.17%$2.87B
Blackrock5.47M11.64%$1.74B
Vanguard group4.18M9.53%$2.03B
Avoro capital advisors2.78M6.39%$1.51B
Vanguard capital management1.92M4.41%$1.04B
State street1.90M4.36%$1.03B
Renaissance1.71M3.93%$925.85M
Wellington management group llp1.38M3.17%$747.20M
Geode capital management996.60K2.29%$538.86M
Janus henderson group866.93K1.96%$514.02M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Krensavage asset management69.28K14.26%$37.54M
Avoro capital advisors2.78M13.52%$1.51B
Darwin global management748.55K8.83%$317.62M
Eversept partners, lp287.67K8.09%$155.87M
Vilga financial planning20.00K6.47%$10.84M
Vestal point capital, lp435.00K5.51%$235.70M
Nepsis30.34K5.18%$16.44M
First turn management84.93K4.92%$46.02M
Palo alto investors lp62.59K4.69%$33.91M
Soleus capital management225.59K4.21%$122.23M

Top Buyers

HolderShares% AssetsChange
Darwin global management748.55K8.83%748.55K
Norges bank694.75K0.04%694.75K
Vestal point capital, lp435.00K5.51%360.00K
Sixth street partners management company297.16K0.02%297.16K
Jane street group285.93K0.01%283.17K

Top Sellers

HolderShares% AssetsChange
Wellington management group llp1.38M0.13%-885.22K
Vaughan nelson investment management---328.78K
Aqr capital management546.00K0.10%-280.22K
Vanguard group4.18M0.03%-242.59K
Geode capital management996.60K0.03%-236.43K

New Positions

HolderShares% AssetsChangeValue
Darwin global management748.55K8.83%748.55K$317.62M
Norges bank694.75K0.04%694.75K$376.44M
Sixth street partners management company297.16K0.02%297.16K$161.01M
Deep track capital, lp123.62K0.97%123.62K$66.98M
Kynam capital management, lp67.59K1.49%67.59K$20.01M

Sold Out

HolderChange
Chilton capital management-1.00
Financial gravity asset management-1.00
Advisornet financial-1.00
Raleigh capital management-1.00
Financial synergies wealth advisors-1.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026887-0.67%41,889,8170.94%961.06%4210.72%3281.23%
Mar 31, 2026482-43.29%12,599,762-69.70%280.32%218-53.81%174-33.59%
Dec 31, 2025589-21.05%26,681,650-34.76%600.74%320-4.76%186-33.33%
Sep 30, 20257085.20%40,294,923-2.97%891.05%319-10.64%26425.71%
Jun 30, 20256810.59%43,719,199-1.26%961.00%3584.99%214-4.89%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Mid-Cap ETF1.53M3.56%-540.00
Vanguard MStar Total Stk Mkt Idx Invest1.36M3.18%13.62K
Vanguard Total Stock Mkt Idx Inv1.35M3.18%-47.08K
Vanguard Morn Total Stk Mkt Idx Investor1.35M3.18%-47.08K
Vanguard US Total Market Shares ETF1.41M3.14%1.06K
Vanguard Small Cap Index965.42K2.25%-11.26K
Vanguard Health Care Inv756.63K1.78%-99.11K
Vanguard Institutional Extnd Mkt Idx Tr488.78K1.14%1.75K
Vanguard Windsor Investor Shares488.35K1.09%-40.43K
SPDR® S&P Biotech ETF424.26K0.94%945.00

Recent Insider Transactions

DateNameRoleActivityValue
Oct 27, 2026ROTHBLATT MARTINE A Chairperson & CEOSell$828.70K
Oct 27, 2026ROTHBLATT MARTINE A Chairperson & CEOSell$275.29K
Oct 27, 2026ROTHBLATT MARTINE A Chairperson & CEOSell$51.86K
Oct 27, 2026ROTHBLATT MARTINE A Chairperson & CEOSell$471.24K
Oct 27, 2026ROTHBLATT MARTINE A Chairperson & CEOSell$831.67K

Insider Transactions Trends

DateBuySell
2026 Q4-292
2026 Q3-751
2026 Q21976
2026 Q1-459
2025 Q4-383

UTHR Ownership FAQ

Who Owns United Therapeutics?

United Therapeutics shareholders are primarily institutional investors at 96.30%, followed by 2.03% insiders and 1.67% retail investors. The average institutional ownership in United Therapeutics's industry, Biotech Stocks , is 384.82%, which United Therapeutics falls below.

Who owns the most shares of United Therapeutics?

United Therapeutics’s largest shareholders are Blackrock funding, inc. /de (5.29M shares, 12.17%), Blackrock (5.47M shares, 11.64%), and Vanguard group (4.18M shares, 9.53%). Together, they hold 33.34% of United Therapeutics’s total shares outstanding.

Does Blackrock own United Therapeutics?

Yes, BlackRock owns 11.64% of United Therapeutics, totaling 5.47M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.74B$. In the last quarter, BlackRock decreased its holdings by -98.516K shares, a -1.77% change.

Who is United Therapeutics’s biggest shareholder by percentage of total assets invested?

Krensavage asset management is United Therapeutics’s biggest shareholder by percentage of total assets invested, with 14.26% of its assets in 69.28K United Therapeutics shares, valued at 37.54M$.

Who is the top mutual fund holder of United Therapeutics shares?

iShares Core S&P Mid-Cap ETF is the top mutual fund holder of United Therapeutics shares, with 3.56% of its total shares outstanding invested in 1.53M United Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools